Syndax Pharmaceuticals Inc (SNDX)
Healthcare
Biotechnology
19.10 $
-2.2%
vs. previous close
Closing price · As of: 31. Jul 2026
Syndax Pharmaceuticals Inc (SNDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -50 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -35 | -45 | -41 | -84 | -72 | -62 | -57 | -95 | -88 | -71 | -69 | -50 | -278 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | -0.2 | 0.0 | 0.0 | -0.1 | |
| 8.1 | 8.3 | 8.3 | 8.9 | 9.9 | 12 | 12 | 10 | 14 | 12 | 11 | 12 | 49 | |
| 8.1 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 4.7 | 1.6 | 26 | -16 | -10 | 13 | 27 | -17 | -27 | -23 | -12 | -19 | -81 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.2 | |
| 74 | 40 | -16 | -99 | 62 | 87 | -269 | 94 | 42 | 72 | 82 | 38 | 234 | |
| 1.3 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.3 | 1.9 | 258 | 2.2 | 0.7 | 3.1 | 347 | 0.9 | 0.6 | 6.3 | 5.9 | 7.9 | 21 | |
| 40 | -2.7 | 201 | -181 | -9.2 | 28 | 21 | -0.1 | -45 | 8.2 | 18 | -4.0 | -23 | |
| -35 | -45 | -41 | -84 | -72 | -62 | -57 | -95 | -88 | -71 | -70 | -50 | -278 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.